Instant Access

Drug Pharmacy Compounding

4109
Duration60 Minutes
Rachelle D'Souza
Instructor

Rachelle D'Souza

View profile

This webinar will discuss conditions under which certain compounded human drug products are exempted from compliance with cGMPs, labeling, market approval and reporting requirements. It will cover conditions that require an outsourcing facility to comply and the latest developments in drug pharmacy compounding.

Course Objective:

Do you know of sections 503A and 503B of the Federal Food, Drug and Cosmetic Act (FDCA) as it relates to drug compounding?

Section 503A provides conditions under which certain compounded human drug products are exempted from requirements such as compliance with current good manufacturing practices (CGMPs), labeling with adequate directions for use and FDA market approval. New section 503B of the FDCA enables a compounder to register with FDA to become an “outsourcing facility.” Outsourcing facilities are exempt from the above label compliance and FDA market approval requirements but are still subject to CGMP compliance, risk based FDA inspections and certain reporting requirements such as adverse event reporting.

This training seeks to inform hospital or stand-alone pharmacies, pharmacy state boards, pharmacists, health care professionals, hospitals on the various FDA documents including the latest developments concerning this topic.

Course Outline:

• Sections 503A and 503B,
• FDCA & various FDA documentation concerning this topic
• Outsourcing facility registration and reporting

What You Get:

•  Training Materials
•  Live Q&A Session with our Expert
•  Participation Certificate
•  Access to Signup Community (Optional)
•  Reward Points

Who Will Benefit:

• Hospitals or stand-alone pharmacies
• Pharmacy state boards
• Pharmacists
• Health care professionals
• Compliance officers
• Documentation specialists

Please reach us at 1-888-844-8963 for any further assistance or if you wish to register

100% MONEY BACK GUARANTEED

Refund / Cancellation policy

Get In Touch

Subject : Drug Pharmacy Compounding


Similar Trainings

Understanding the FDA Compounding Pharmacies Guidance
Life Sciences Pharmaceutical | Biotchnology | Laboratory
Get Instant Access 60 Minutes
View Program
FDA Regulatory Control of the Drug Development Process and Investigator Responsibility in the Process
Life Sciences Pharmaceutical | Biotchnology | Laboratory
Get Instant Access 90 Minutes
View Program
Biopharmaceutic Considerations in Drug Product Design and In Vitro Drug Product Performance
Life Sciences Pharmaceutical | Biotchnology | Laboratory
Get Instant Access 90 Minutes
View Program
Understanding The Regulation of Prescription Drugs
Life Sciences Pharmaceutical | Biotchnology | Laboratory
Get Instant Access 90 Minutes
View Program
Vendor Qualification - Evaluating Vendors & Understanding their Capabilities
Life Sciences Pharmaceutical | Biotchnology | Laboratory
Get Instant Access 60 Minutes
View Program